BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11528305)

  • 1. Phenylephrine and ECS-induced retrograde amnesia.
    Anand A; Andrade C; Sudha S; Guido S; Venkataraman BV
    J ECT; 2001 Sep; 17(3):166-9. PubMed ID: 11528305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitroprusside and ECS-induced retrograde amnesia.
    Sudha S; Andrade C; Anand A; Guido S; Venkataraman BV
    J ECT; 2001 Mar; 17(1):41-4. PubMed ID: 11281514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT.
    Andrade C; Thyagarajan S; Singh NM; Vinod PS; Sanjay Kumar Rao N; Chandra JS
    J Neural Transm (Vienna); 2008 Jul; 115(7):1063-70. PubMed ID: 18523723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature.
    Andrade C; Singh NM; Thyagarajan S; Nagaraja N; Sanjay Kumar Rao N; Suresh Chandra J
    J Psychiatr Res; 2008 Aug; 42(10):837-50. PubMed ID: 17937934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.
    Nagaraja N; Andrade C; Sudha S; Madan Singh N; Chandra JS; Venkataraman BV
    Psychopharmacology (Berl); 2007 Jan; 190(1):73-80. PubMed ID: 17072590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of stimulus intensity and number of treatments on ECS-related seizure duration and retrograde amnesia in rats.
    Andrade C; Thyagarajan S; Vinod PS; Srikanth SN; Rao NS; Chandra JS
    J ECT; 2002 Dec; 18(4):197-202. PubMed ID: 12468995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pre-ECS antihypertensive drug administration in the attenuation of ECS-induced retrograde amnesia.
    Kamath S; Andrade C; Faruqi S; Venkataraman BV; Naga Rani MA; Candade VS
    Convuls Ther; 1997 Sep; 13(3):185-95. PubMed ID: 9342135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromolysergide and methysergide protection against ECS-induced retrograde amnesia.
    Montanaro N; Dall'Olio R; Gandolfi O
    Neuropsychobiology; 1979; 5(3):174-80. PubMed ID: 34806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial memory impairment in Morris water maze after electroconvulsive seizures.
    Svensson M; Hallin T; Broms J; Ekstrand J; Tingström A
    Acta Neuropsychiatr; 2017 Feb; 29(1):17-26. PubMed ID: 27139778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).
    Moscrip TD; Terrace HS; Sackeim HA; Lisanby SH
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):1-11. PubMed ID: 16045810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.
    Andrade C; Shaikh SA; Narayan L; Blasey C; Belanoff J
    J Neural Transm (Vienna); 2012 Mar; 119(3):337-44. PubMed ID: 21922193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of stimulus parameters on seizure duration and ECS-induced retrograde amnesia.
    Andrade C; Suresh S; Krishnan J; Venkataraman BV
    J ECT; 2002 Mar; 18(1):31-7. PubMed ID: 11925519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-electroconvulsive shock administration of calcium channel blockers reduces retrograde amnesia induced by ECS.
    Sushma M; Sudha S; Guido S
    Indian J Exp Biol; 2004 Nov; 42(11):1141-4. PubMed ID: 15587124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive shock and brain muscarinic receptors: relationship to anterograde amnesia.
    Lerer B; Stanley M; McIntyre I; Altman H
    Life Sci; 1984 Dec; 35(26):2659-64. PubMed ID: 6513731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal pharmacotherapy for the attenuation of electroconvulsive shock-induced anterograde and retrograde amnestic deficits.
    Faruqi S; Andrade C; Ramteke S; Joseph J; Venkataraman BV; Naga Rani MA
    Convuls Ther; 1995 Dec; 11(4):241-7. PubMed ID: 8919574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study.
    Prudic J; Fitzsimons L; Nobler MS; Sackeim HA
    Neuropsychopharmacology; 1999 Aug; 21(2):285-93. PubMed ID: 10432476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primate model of anterograde and retrograde amnesia produced by convulsive treatment.
    Moscrip TD; Terrace HS; Sackeim HA; Lisanby SH
    J ECT; 2004 Mar; 20(1):26-36. PubMed ID: 15087994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of ECS-induced retrograde amnesia by using an herbal formulation.
    Vinekar AS; Andrade C; Sriprada VT; George J; Joseph T; Chandra JS
    J ECT; 1998 Jun; 14(2):83-8. PubMed ID: 9641803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde amnesia produced by several treatments: evidence for a common neurobiological mechanism.
    Gold PE; Sternberg DB
    Science; 1978 Jul; 201(4353):367-9. PubMed ID: 208153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT-induced anterograde amnesia: can the deficits be minimized?
    Andrade C; Joseph J; Chandra JS; Vankataraman BV; Rani MA
    Convuls Ther; 1994 Mar; 10(1):59-64. PubMed ID: 8055293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.